觀察名單觀點 ProPicks AI 篩選器數據瀏覽圖表已儲存工作 WarrenAI

Dr Soliman Abdel Kader Fakeeh

SASE:4017

沙特阿拉伯 / 保健 / 醫療保健供應和服務

綜觀

5 年 DCF EBITDA 退出價

股價

45.10 SAR

公允價值

40.36 SAR

Metrics	Range	Conclusion
Discount Rate	8.8% - 7.8%	8.3%
Terminal EBITDA Multiple	7.8x - 9.8x	8.8x
Fair Value	﷼34.52 - ﷼46.43	﷼40.36
Upside	-23.5% - 3.0%	-10.5%

15.8%

Revenue 5y CAGR

22.1%

5y Avg EBITDA Margin

Unlevered FCF 5y CAGR

5-Year DCF Model: EBITDA Exit

股價

45.10 SAR

公允價值

40.36 SAR

看漲

-10.5%

Revenue and EBITDA

CapEx

Working Capital

D&A

Tax Rate

Discount Rate

Terminal Value


Select Revenue and EBITDA Forecast

(SAR in millions)		Input Projections
Fiscal Years Ending	Dec-24	Dec-25	Dec-26	Dec-27	Dec-28	Dec-29

Revenue	2,791	3,149	3,720	4,441	5,269	5,812
% Growth	20.0%	12.8%	18.1%	19.4%	18.7%	10.3%

EBITDA	461	556	730	878	1,317	1,646
% of Revenue	16.5%	17.7%	19.6%	19.8%	25.0%	28.3%

支援算式

Calculation of Free Cash Flow

Discounting Periods

Discounting Factors

Calculation of Enterprise Value

Equity Waterfall

Historical Financials

Current Trading Multiples


Calculation of Free Cash Flow

Projected Unlevered Cash Flow
(SAR in millions)		Dec-25	Dec-26	Dec-27	Dec-28	Dec-29

EBITDA		556	730	878	1,317	1,646
Other Income / (Exp)		0	0	0	0	0
D&A		(219)	(192)	(270)	(411)	(729)

EBIT		338	538	608	906	917
Pro forma Taxes		(24)	(38)	(43)	(63)	(64)
NOPAT	334	314	501	565	843	853

Capital Expenditures	(480)	(896)	(1,071)	(922)	(528)	(233)
NWC Investment	(134)	(104)	(165)	(209)	(240)	(157)
(+) D&A	101	219	192	270	411	729

Free Cash Flow	(179)	(466)	(544)	(295)	486	1,192
% Growth		NM	NM	NM	NM	145%

載入錯誤

Dr Soliman Abdel Kader Fakeeh

SASE:4017

沙特阿拉伯 / 保健 / 醫療保健供應和服務

5 年 DCF EBITDA 退出價